Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woods, C. G.
Right arrow Articles by Rusyn, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woods, C. G.
Right arrow Articles by Rusyn, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 35, No. 4, 474-494 (2007)
DOI: 10.1080/01926230701311351
© 2007 Society of Toxicologic Pathology

Genomic Profiling in Nuclear Receptor-Mediated Toxicity

Courtney G. Woods

Department of Environmental Sciences and Engineering, University of North Carolina, Chapel Hill, North Carolina 27599, USA

John P. Vanden Heuvel

Department of Veterinary and Biomedical Sciences and Center for Molecular Toxicology and Carcinogenesis, Pennsylvania State University, University Park, Pennsylvania 16802, USA

Ivan Rusyn

Department of Environmental Sciences and Engineering, University of North Carolina, Chapel Hill, North Carolina 27599, USA, iir{at}unc.edu

Nuclear receptors (NRs) are attractive drug targets due to their role in regulation of a wide range of physiologic responses. In addition to providing therapeutic value, many pharmaceutical agents along with environmental chemicals are ligands for NRs and can cause adverse health effects that are directly related to activation of NRs. Identifying the molecular events that produce a toxic response may be confounded by the fact that there is a significant overlap in the biological processes that NRs regulate. Microarrays and other methods for gene expression profiling have served as useful, sensitive tools for discerning the mechanisms by which therapeutics and environmental chemicals invoke toxic effects. The capability to probe thousands of genes simultaneously has made genomics a prime technology for identifying drug targets, biomarkers of exposure/toxicity and key players in the mechanisms of disease. The complex intertwining networks regulated by NRs are hard to probe comprehensively without global approaches and genomics has become a key technology that facilitates our understanding of NR-dependent and -independent events. The future of drug discovery, design and optimization, and risk assessment of chemical toxicants that activate NRs will inevitably involve genomic profiling. This review will focus on genomics studies related to PPAR, CAR, PXR, RXR, LXR, FXR, and AHR.

Key Words: Toxicogenomics • nuclear receptor • transcription profiling • PPAR • CAR • PXR • AHR.

References

  • Akerman, P., Cote, P., Yang, S.Q., McClain, C., Nelson, S., Bagby, G.J., and Diehl, A.M. (1992). Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol 263, G579—85.[ISI][Medline] [Order article via Infotrieve]
  • Alarcon, D.I.L., Sanchez-Fidalgo, S., Villegas, I., and Motilva, V. (2004). New pharmacological perspectives and therapeutic potential of PPAR-gamma agonists. Curr Pharm Des 10, 3505—24.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Aldridge, T.C., Tugwood, J.D., and Green, S. (1995). Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem J 306 (Pt 2), 473—9.[ISI][Medline] [Order article via Infotrieve]
  • Amri, E.Z., Bonino, F., Ailhaud, G., Abumrad, N.A., and Grimaldi, P.A. (1995). Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 270, 2367—71.[Abstract/Free Full Text]
  • Anderson, S.P., Dunn, C., Laughter, A., Yoon, L., Swanson, C., Stulnig, T.M., Steffensen, K.R., Chandraratna, R.A., Gustafsson, J.A., and Corton, J.C. (2004). Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver. Mol Pharmacol 66, 1440— 52.
  • Aranda, A., and Pascual, A. (2001). Nuclear hormone receptors and gene expression. Physiol Rev 81, 1269—304.[Abstract/Free Full Text]
  • Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J.P., Staels, B., Auwerx, J., Laville, M., and Vidal, H. (1997). Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46, 1319— 27.[ISI]
  • Bagchi, D., Balmoori, J., Bagchi, M., Ye, X., Williams, C.B., and Stohs, S.J. (2002). Comparative effects of TCDD, endrin, naphthalene and chromium (VI) on oxidative stress and tissue damage in the liver and brain tissues of mice. Toxicology 175, 73—82.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Baker, V.A., Harries, H.M., Waring, J.F., Duggan, C.M., Ni, H.A., Jolly, R.A., Yoon, L.W., De Souza, A.T., Schmid, J.E., Brown, R.H., Ulrich, R.G., and Rockett, J.C. (2004). Clofibrate-induced gene expression changes in rat liver: a cross-laboratory analysis using membrane cDNA arrays. Environ Health Perspect 112, 428—38.[ISI][Medline] [Order article via Infotrieve]
  • Bammler, T., Beyer, R.P., Bhattacharya, S., Boorman, G.A., Boyles, A., Bradford, B.U., Bumgarner, R.E., Bushel, P.R., Chaturvedi, K., Choi, D., Cunningham, M.L., Deng, S., Dressman, H.K., Fannin, R.D., Farin, F.M., Freedman, J.F., Fry, R.C., Harper, A., Humble, M.C., Hurban, P., Kavanagh, T.J., Kaufmann, W.K., Kerr, K.F., Jing, L., Lapidus, J.A., Lasarev, M.R., Li, J., Li, Y.J., Lobenhofer, E.K., Lu, X., Malek, R.L., Milton, S., Nagalla, S.R., O'Malley, J.P., Palmer, V.S., Pattee, P., Paules, R.S., Perou, C.M., Phillips, K., Qin, L., Qiu, Y., Quigley, S.D., Rodland, M., Rusyn, I., Samson, L.D., Schwartz, D.A., Shi, Y., Shin, J.L., Sieber, S.O., Slifer, S., Speer, M.C., Spencer, P.S., Sproles, D.I., Swenberg, J.A., Suk, W.A., Sullivan, R.C., Tian, R., Tennant, R.W., Todd, S.A., Tucker, C.J., Houten, B.V., Weis, B.K., Xuan, S., Zarbl, H., and Members of the Toxicogenomics Research Consortium (2005). Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2, 351—6.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., and Wiegand, H.J. (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem Toxicol 31, 857—907.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Biegel, L.B., Hurtt, M.E., Frame, S.R., O'Connor, J.C., and Cook, J.C. (2001). Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol Sci 60, 44—55.[Abstract/Free Full Text]
  • Bittinger, M.A., Nguyen, L.P., and Bradfield, C.A. (2003). Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor. Mol Pharmacol 64, 550—6.[Abstract/Free Full Text]
  • Blumberg, B., and Evans, R.M. (1998). Orphan nuclear receptors—new ligands and new possibilities. Genes Dev 12, 3149—55.[Free Full Text]
  • Boverhof, D.R., Burgoon, L.D., Tashiro, C., Chittim, B., Harkema, J.R., Jump, D.B., and Zacharewski, T.R. (2005). Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity. Toxicol Sci 85, 1048—63.[Abstract/Free Full Text]
  • Braissant, O., Foufelle, F., Scotto, C., Dauca, M., and Wahli, W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354—66.[Abstract]
  • Brem, A.S., Bina, R.B., Mehta, S., and Marshall, J. (1999). Glucocorticoids inhibit the expression of calcium-dependent potassium channels in vascular smooth muscle. Mol Genet Metab 67, 53—7.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Bunger, M.K., Moran, S.M., Glover, E., Thomae, T.L., Lahvis, G.P., Lin, B.C., and Bradfield, C.A. (2003). Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying amutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J Biol Chem 278, 17767—74.[Abstract/Free Full Text]
  • Burk, R.F., Hill, K.E., Hunt, R.W., Jr., and Martin, A.E. (1990). Isoniazid potentiation of acetaminophen hepatotoxicity in the rat and 4-methylpyrazole inhibition of it. Res Commun Chem Pathol Pharmacol 69, 115—8.[ISI][Medline] [Order article via Infotrieve]
  • Butterworth, B.E. (1990). Consideration of both genotoxic and nongenotoxic mechanisms in predicting carcinogenic potential. Mutat Res 239, 117— 32.
  • Cao, G., Liang, Y., Broderick, C.L., Oldham, B.A., Beyer, T.P., Schmidt, R.J., Zhang, Y., Stayrook, K.R., Suen, C., Otto, K.A., Miller, A.R., Dai, J., Foxworthy, P., Gao, H., Ryan, T.P., Jiang, X.C., Burris, T.P., Eacho, P.I., and Etgen, G.J. (2003). Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem 278, 1131—6.[Abstract/Free Full Text]
  • Cariello, N.F., Romach, E.H., Colton, H.M., Ni, H., Yoon, L., Falls, J.G., Casey, W., Creech, D., Anderson, S.P., Benavides, G.R., Hoivik, D.J., Brown, R., and Miller, R.T. (2005). Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver. Toxicol Sci 88, 250—64.[Abstract/Free Full Text]
  • Carleton, R.A., Dwyer, J., Finberg, L., Flora, J., Goodman, D.S., Grundy, S.M., Havas, S., Hunter, G.T., Kritchevsky, D., Lauer, R.M., and (1991). Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Circulation 83, 2154—232.[ISI][Medline] [Order article via Infotrieve]
  • Castrillo, A., Joseph, S.B., Vaidya, S.A., Haberland, M., Fogelman, A.M., Cheng, G., and Tontonoz, P. (2003). Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 12, 805—16.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Ceciliani, F., Giordano, A., and Spagnolo, V. (2002). The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett 9, 211— 23.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Chen, J.D., and Evans, R.M. (1995). A transcriptional co-repressorthat interacts with nuclear hormone receptors. Nature 377, 454—7.[CrossRef][Medline] [Order article via Infotrieve]
  • Chen, W., Owsley, E., Yang, Y., Stroup, D., and Chiang, J.Y. (2001). Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids. J Lipid Res 42, 1402—12.[Abstract/Free Full Text]
  • Cherkaoui-Malki, M., Meyer, K., Cao, W.Q., Latruffe, N., Yeldandi, A.V., Rao, M.S., Bradfield, C.A., and Reddy, J.K. (2001). Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. Gene Expr 9, 291— 304.[ISI][Medline] [Order article via Infotrieve]
  • Chiang, J.Y. (2003). Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol Gastrointest Liver Physiol 284, G349— 56.
  • Collins, F.S., Morgan, M., and Patrinos, A. (2003). The Human Genome Project: lessons from large-scale biology. Science 300, 286—90.[Abstract/Free Full Text]
  • Columbano, A., Ledda-Columbano, G.M., Pibiri, M., Cossu, C., Menegazzi, M., Moore, D.D., Huang, W., Tian, J., and Locker, J. (2005). Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology 42, 1118—26.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Columbano, A., Rajalakshmi, S., and Sarma, D.S. (1981). Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res 41, 2079—83.[Abstract/Free Full Text]
  • Currie, R.A., Bombail, V., Oliver, J.D., Moore, D.J., Lim, F.L., Gwilliam, V., Kimber, I., Chipman, K., Moggs, J.G., and Orphanides, G. (2005). Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate. Toxicol Sci 86, 453—69.[Abstract/Free Full Text]
  • Dai, G., Chou, N., He, L., Gyamfi, M.A., Mendy, A.J., Slitt, A.L., Klaassen, C.D., and Wan, Y.J. (2005). Retinoid X receptor alpha regulates the expression of glutathione s-transferase genes and modulates acetaminophen-glutathione conjugation in mouse liver. Mol Pharmacol 68, 1590—6.[Abstract/Free Full Text]
  • de Longueville, F., Atienzar, F.A., Marcq, L., Dufrane, S., Evrard, S., Wouters, L., Leroux, F., Bertholet, V., Gerin, B., Whomsley, R., Arnould, T., Remacle, J., and Canning, M. (2003). Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. Toxicol Sci 75, 378—92.[Abstract/Free Full Text]
  • De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D.U., Jin, R., Jones, J., Cong, R., and Franzoso, G. (2001). Induction of gadd45beta by NF-kappaB down-regulates pro-apoptotic JNK signalling. Nature 414, 308—13.[CrossRef][Medline] [Order article via Infotrieve]
  • Dietschy, J.M., and Turley, S.D. (2004). Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45, 1375—97.[Abstract/Free Full Text]
  • Dirven, H.A., van den Broek, P.H., Peeters, M.C., Peters, J.G., Mennes, W.C., Blaauboer, B.J., Noordhoek, J., and Jongeneelen, F.J. (1993). Effects of the peroxisome proliferator mono(2-ethylhexyl)phthalate in primary hepatocyte cultures derived from rat, guinea pig, rabbit, and monkey. Biochem Pharmacol 45, 2425—34.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Diwan, B.A., Lubet, R.A., Ward, J.M., Hrabie, J.A., and Rice, J.M. (1992). Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine. Carcinogenesis 13, 1893—901.[Abstract/Free Full Text]
  • Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., and Wahli, W. (1992). Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879—87.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Eloranta, J.J., and Kullak-Ublick, G.A. (2005). Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 433, 397—412.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Elrick, M.M., Kramer, J.A., Alden, C.L., Blomme, E.A., Bunch, R.T., Cabonce, M.A., Curtiss, S.W., Kier, L.D., Kolaja, K.L., Rodi, C.P., and Morris, D.L. (2005). Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity. Toxicol Pathol 33, 118— 26.[Abstract/Free Full Text]
  • Engelbrecht, Y., de Wet, H., Horsch, K., Langeveldt, C.R., Hough, F.S., and Hulley, P.A. (2003). Glucocorticoids induce rapid up-regulation of mitogenactivated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144, 412—22.[Abstract/Free Full Text]
  • Fletcher, N., Wahlstrom, D., Lundberg, R., Nilsson, C.B., Nilsson, K.C., Stockling, K., Hellmold, H., and Hakansson, H. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicol Appl Pharmacol 207, 1—24.[ISI][Medline] [Order article via Infotrieve]
  • Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M., and Evans, R.M. (1995). 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803— 12.
  • Frueh, F.W., Hayashibara, K.C., Brown, P.O., and Whitlock, J.P., Jr. (2001). Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression. Toxicol Lett 122, 189—203.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Geick, A., Eichelbaum, M., and Burk, O. (2001). Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276, 14581—7.[Abstract/Free Full Text]
  • Glass, C.K., and Rosenfeld, M.G. (2000). The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14, 121—41.[Free Full Text]
  • Goetz, A.K., Bao, W., Ren, H., Schmid, J.E., Tully, D.B., Wood, C., Rockett, J.C., Narotsky, M.G., Sun, G., Lambert, G.R., Thai, S.F., Wolf, D.C., Nesnow, S., and Dix, D.J. (2006). Gene expression profiling in the liver of CD-1 mice to characterize the hepatotoxicity of triazole fungicides. Toxicol Appl Pharmacol 215, 274—84.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Gonzalez, F.J., Peters, J.M., and Cattley, R.C. (1998). Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha. J Natl Cancer Inst 90, 1702—9.[Abstract/Free Full Text]
  • Graham, M.J., Wilson, S.A., Winham, M.A., Spencer, A.J., Rees, J.A., Old, S.L., and Bonner, F.W. (1994). Lack of peroxisome proliferation in marmoset liver following treatment with ciprofibrate for 3 years. Fund Appl Toxicol 22, 58—64.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Gregory, S.G., Sekhon, M., Schein, J., Zhao, S., Osoegawa, K., Scott, C.E., Evans, R.S., Burridge, P.W., Cox, T.V., Fox, C.A., Hutton, R.D., Mullenger, I.R., Phillips, K.J., Smith, J., Stalker, J., Threadgold, G.J., Birney, E., Wylie, K., Chinwalla, A., Wallis, J., Hillier, L., Carter, J., Gaige, T., Jaeger, S., Kremitzki, C., Layman, D., Maas, J., McGrane, R., Mead, K., Walker, R., Jones, S., Smith, M., Asano, J., Bosdet, I., Chan, S., Chittaranjan, S., Chiu, R., Fjell, C., Fuhrmann, D., Girn, N., Gray, C., Guin, R., Hsiao, L., Krzywinski, M., Kutsche, R., Lee, S.S., Mathewson, C., McLeavy, C., Messervier, S., Ness, S., Pandoh, P., Prabhu, A.L., Saeedi, P., Smailus, D., Spence, L., Stott, J., Taylor, S., Terpstra, W., Tsai, M., Vardy, J., Wye, N., Yang, G., Shatsman, S., Ayodeji, B., Geer, K., Tsegaye, G., Shvartsbeyn, A., Gebregeorgis, E., Krol, M., Russell, D., Overton, L., Malek, J.A., Holmes, M., Heaney, M., Shetty, J., Feldblyum, T., Nierman, W.C., Catanese, J.J., Hubbard, T., Waterston, R.H., Rogers, J., de Jong, P. J., Fraser, C. M., Marra, M., McPherson, J. D., and Bentley, D. R. (2002). A physical map of the mouse genome. Nature 418, 743—50.[CrossRef][Medline] [Order article via Infotrieve]
  • Gulick, T., Cresci, S., Caira, T., Moore, D.D., and Kelly, D.P. (1994). The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91, 11012—6.[Abstract/Free Full Text]
  • Guo, G.L., Moffit, J.S., Nicol, C.J., Ward, J.M., Aleksunes, L.A., Slitt, A.L., Kliewer, S.A., Manautou, J.E., and Gonzalez, F.J. (2004). Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol Sci 82, 374—80.[Abstract/Free Full Text]
  • Hagenbuch, N., Reichel, C., Stieger, B., Cattori, V., Fattinger, K.E., Landmann, L., Meier, P.J., and Kullak-Ublick, G.A. (2001). Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. J Hepatol 34, 881—7.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Hamadeh, H.K., Bushel, P.R., Jayadev, S., Martin, K., DiSorbo, O., Sieber, S., Bennett, L., Tennant, R., Stoll, R., Barrett, J.C., Blanchard, K., Paules, R.S., and Afshari, C.A. (2002). Gene expression analysis reveals chemicalspecific profiles. Toxicol Sci 67, 219—31.[Abstract/Free Full Text]
  • Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35, 307—40.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Harstad, E.B., Guite, C.A., Thomae, T.L., and Bradfield, C.A. (2006). Liver deformation in Ahr-null mice: evidence for aberrant hepatic perfusion in early development. Mol Pharmacol 69, 1534—41.[Abstract/Free Full Text]
  • Hayes, K.R., Vollrath, A.L., Zastrow, G.M., McMillan, B.J., Craven, M., Jovanovich, S., Rank, D.R., Penn, S., Walisser, J.A., Reddy, J.K., Thomas, R.S., and Bradfield, C.A. (2005). EDGE: a centralized resource for the comparison, analysis, and distribution of toxicogenomic information. Mol Pharmacol 67, 1360—8.[Abstract/Free Full Text]
  • He, G., Muga, S., Thuillier, P., Lubet, R.A., and Fischer, S.M. (2005). The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin. Mol Carcinog 43, 198—206.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Heath-Pagliuso, S., Rogers, W.J., Tullis, K., Seidel, S.D., Cenijn, P.H., Brouwer, A., and Denison, M.S. (1998). Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry 37, 11508— 15.
  • Heinloth, A.N., Irwin, R.D., Boorman, G.A., Nettesheim, P., Fannin, R.D., Sieber, S.O., Snell, M.L., Tucker, C.J., Li, L., Travlos, G.S., Vansant, G., Blackshear, P.E., Tennant, R.W., Cunningham, M.L., and Paules, R.S. (2004). Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol Sci 80, 193—202.[Abstract/Free Full Text]
  • Hino, S., Kawamata, H., Omotehara, F., Uchida, D., Miwa, Y., Begum, N.M., Yoshida, H., Sato, M., and Fujimori, T. (2002). Cytoplasmic TSC-22 (transforming growth factor-beta-stimulated clone-22) markedly enhances the radiation sensitivity of salivary gland cancer cells. Biochem Biophys Res Commun 292, 957—63.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Hochepied, T., Berger, F.G., Baumann, H., and Libert, C. (2003). Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 14, 25— 34.
  • Hoivik, D.J., Qualls, C.W., Jr., Mirabile, R.C., Cariello, N.F., Kimbrough, C.L., Colton, H.M., Anderson, S.P., Santostefano, M.J., Morgan, R.J., Dahl, R.R., Brown, A.R., Zhao, Z., Mudd, P.N., Jr., Oliver, W.B., Jr., Brown, H.R., and Miller, R.T. (2004). Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys. Carcinogenesis 25, 1757— 69.[Abstract/Free Full Text]
  • Honkakoski, P. and Negishi, M. (2000). Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochem J 347, 321—37.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Huang, W., Zhang, J., Chua, S.S., Qatanani, M., Han, Y., Granata, R., and Moore, D.D. (2003). Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci USA 100, 4156—61.[Abstract/Free Full Text]
  • Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J.M., Lozano, G., and Moore, D.D. (2005). Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol 19, 1646—53.[Abstract/Free Full Text]
  • Hurley, P.M. (1998). Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environ Health Perspect 106, 437—45.[ISI][Medline] [Order article via Infotrieve]
  • Iba, M.M., Alam, J., Touchard, C., Thomas, P.E., Ghosal, A., and Fung, J. (1999). Coordinate up-regulation of CYP1A1 and heme oxygenase-1 (HO1) expression and modulation of delta-aminolevulinic acid synthase and tryptophan pyrrolase activities in pyridine-treated rats. Biochem Pharmacol 58, 723—34.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Ide, T., Shimano, H., Yoshikawa, T., Yahagi, N., Amemiya-Kudo, M., Matsuzaka, T., Nakakuki, M., Yatoh, S., Iizuka, Y., Tomita, S., Ohashi, K., Takahashi, A., Sone, H., Gotoda, T., Osuga, J., Ishibashi, S., and Yamada, N. (2003). Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Mol Endocrinol 17, 1255—67.[Abstract/Free Full Text]
  • Janowski, B.A., Willy, P.J., Devi, T.R., Falck, J.R., and Mangelsdorf, D.J. (1996). An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383, 728—31.[CrossRef][Medline] [Order article via Infotrieve]
  • Johnson, E.F., Hsu, M.H., Savas, U., and Griffin, K.J. (2002). Regulation of P450 4A expression by peroxisome proliferator activated receptors. Toxicology 181—182, 203—6.[CrossRef]
  • Johnson, E.F., Palmer, C.N., Griffin, K.J., and Hsu, M.H. (1996). Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB J 10, 1241—8.[Abstract]
  • Jones, S.A., Moore, L.B., Shenk, J.L., Wisely, G.B., Hamilton, G.A., McKee, D.D., Tomkinson, N.C., LeCluyse, E.L., Lambert, M.H., Willson, T.M., Kliewer, S.A., and Moore, J.T. (2000). The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol 14, 27—39.[Abstract/Free Full Text]
  • Joseph, S.B., Bradley, M.N., Castrillo, A., Bruhn, K.W., Mak, P.A., Pei, L., Hogenesch, J., O'connell, R.M., Cheng, G., Saez, E., Miller, J.F., and Tontonoz, P. (2004). LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119, 299—309.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kalaany, N.Y., and Mangelsdorf, D.J. (2006). LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol 68, 159—91.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kast, H.R., Goodwin, B., Tarr, P.T., Jones, S.A., Anisfeld, A.M., Stoltz, C.M., Tontonoz, P., Kliewer, S., Willson, T.M., and Edwards, P.A. (2002). Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277, 2908—15.[Abstract/Free Full Text]
  • Kastner, P., Grondona, J.M., Mark, M., Gansmuller, A., LeMeur, M., Decimo, D., Vonesch, J.L., Dolle, P., and Chambon, P. (1994). Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 78, 987—1003.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kastner, P., Mark, M., Leid, M., Gansmuller, A., Chin, W., Grondona, J.M., Decimo, D., Krezel, W., Dierich, A., and Chambon, P. (1996). Abnormal spermatogenesis in RXR beta mutant mice. Genes Dev 10, 80—92.[Abstract/Free Full Text]
  • Kersten, S., Mandard, S., Escher, P., Gonzalez, F.J., Tafuri, S., Desvergne, B., and Wahli, W. (2001). The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. FASEB J 15, 1971—8.[Abstract/Free Full Text]
  • Klaunig, J.E., Babich, M.A., Baetcke, K.P., Cook, J.C., Corton, J.C., David, R.M., Deluca, J.G., Lai, D.Y., McKee, R.H., Peters, J.M., Roberts, R.A., and Fenner-Crisp, P.A. (2003). PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol 33, 655— 780.
  • Klaunig, J.E., and Kamendulis, L.M. (2004). The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44, 239—67.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kliewer, S.A., Forman, B.M., Blumberg, B., Ong, E.S., Borgmeyer, U., Mangelsdorf, D.J., Umesono, K., and Evans, R.M. (1994). Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91, 7355—9.[Abstract/Free Full Text]
  • Kliewer, S.A., Lehmann, J.M., and Willson, T.M. (1999). Orphan nuclear receptors: shifting endocrinology into reverse. Science 284, 757— 60.
  • Kliewer, S.A., Moore, J.T., Wade, L., Staudinger, J.L., Watson, M.A., Jones, S.A., McKee, D.D., Oliver, B.B., Willson, T.M., Zetterstrom, R.H., Perlmann, T., and Lehmann, J.M. (1998). An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92, 73—82.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman, R.A., and Evans, R.M. (1992). Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771—4.[CrossRef][Medline] [Order article via Infotrieve]
  • Kluwe, W.M., Haseman, J.K., Douglas, J.F., and Huff, J.E. (1982). The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. J Toxicol Environ Health 10, 797— 815.[ISI][Medline] [Order article via Infotrieve]
  • Kondraganti, S.R., Muthiah, K., Jiang, W., Barrios, R., and Moorthy, B. (2005). Effects of 3-methylcholanthrene on gene expression profiling in the rat using cDNA microarray analyses. Chem Res Toxicol 18, 1634—41. Kostrubsky, V.E., Szakacs, J.G., Jeffery, E.H., Wood, S.G., Bement, W.J., Wrighton, S.A., Sinclair, P.R., and Sinclair, J.F. (1997). Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 143, 315—23.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kotev-Emeth, S., Pitaru, S., Pri-Chen, S., and Savion, N. (2002). Establishment of a rat long-term culture expressing the osteogenic phenotype: dependence on dexamethasone and FGF-2. Connect Tissue Res 43, 606—12.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kramer, J.A., Blomme, E.A., Bunch, R.T., Davila, J.C., Jackson, C.J., gones, P.F., Kolaja, K.L., and Curtiss, S.W. (2003). Transcription profiling distinguishes dose-dependent effects in the livers of rats treated with clofibrate. Toxicol Pathol 31, 417—31.[Abstract/Free Full Text]
  • Kramer, J.A., Curtiss, S.W., Kolaja, K.L., Alden, C.L., Blomme, E.A., Curtiss, W.C., Davila, J.C., Jackson, C.J., and Bunch, R.T. (2004). Acute molecular markers of rodent hepatic carcinogenesis identified by transcription profiling. Chem Res Toxicol 17, 463—70.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kretschmer, X.C., and Baldwin, W.S. (2005). CAR and PXR: xenosensors of endocrine disrupters? Chem Biol Interact 155, 111—28.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kurachi, M., Hashimoto, S., Obata, A., Nagai, S., Nagahata, T., Inadera, H., Sone, H., Tohyama, C., Kaneko, S., Kobayashi, K., and Matsushima, K. (2002). Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive genes in mouse liver by serial analysis of gene expression. Biochem Biophys Res Commun 292, 368—77.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Kurokawa, Y., Takamura, N., Matushima, Y., Imazawa, T., and Hayashi, Y. (1988). Promoting effect of peroxisome proliferators in two-stage rat renal tumorigenesis. Cancer Lett 43, 145—9.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Lalwani, N.D., Reddy, M.K., Qureshi, S.A., and Reddy, J.K. (1981). Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet. Carcinogenesis 2, 645— 50.
  • Lambe, K.G., Woodyatt, N.J., Macdonald, N., Chevalier, S., and Roberts, R.A. (1999). Species differences in sequence and activity of the peroxisome proliferator response element (PPRE) within the acyl CoA oxidase gene promoter. Toxicol Lett 110, 119—27.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Leclercq, I.A., Farrell, G.C., Field, J., Bell, D.R., Gonzalez, F.J., and Robert-son, G.R. (2000). CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105, 1067— 75.
  • Lee, C.H., Olson, P., Hevener, A., Mehl, I., Chong, L.W., Olefsky, J.M., Gonzalez, F.J., Ham, J., Kang, H., Peters, J.M., and Evans, R.M. (2006). PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA 103, 3444—9.[Abstract/Free Full Text]
  • Lee, J.S., Chu, I.S., Mikaelyan, A., Calvisi, D.F., Heo, J., Reddy, J.K., and Thorgeirsson, S.S. (2004). Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 36, 1306—11.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Lee, S.S., Buters, J.T., Pineau, T., Fernandez-Salguero, P., and Gonzalez, F.J. (1996). Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 271, 12063—7.[Abstract/Free Full Text]
  • Lehmann, J.M., Kliewer, S.A., Moore, L.B., Smith-Oliver, T.A., Oliver, B.B., Su, J.L., Sundseth, S.S., Winegar, D.A., Blanchard, D.E., Spencer, T.A., and Willson, T.M. (1997). Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272, 3137—40.[Abstract/Free Full Text]
  • Lehmann, J.M., McKee, D.D., Watson, M.A., Willson, T.M., Moore, J.T., and Kliewer, S.A. (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102, 1016—23.[ISI][Medline] [Order article via Infotrieve]
  • Lu, T.T., Repa, J.J., and Mangelsdorf, D.J. (2001). Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem 276, 37735—8. Luquet, S., Gaudel, C., Holst, D., Lopez-Soriano, J., Jehl-Pietri, C., Fredenrich, A., and Grimaldi, P.A. (2005). Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. Biochim Biophys Acta 1740, 313—7.[Medline] [Order article via Infotrieve]
  • Maglich, J.M., Stoltz, C.M., Goodwin, B., Hawkins-Brown, D., Moore, J.T., and Kliewer, S.A. (2002). Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62, 638—46.[Abstract/Free Full Text]
  • Makishima, M., Okamoto, A.Y., Repa, J.J., Tu, H., Learned, R.M., Luk, A., Hull, M.V., Lustig, K.D., Mangelsdorf, D.J., and Shan, B. (1999). Identification of a nuclear receptor for bile acids. Science 284, 1362—5. Mangelsdorf, D.J., and Evans, R.M. (1995). The RXR heterodimers and orphan receptors. Cell 83, 841—50.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Mangelsdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R.M. (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835—9.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Manz, A., Berger, J., Dwyer, J.H., Flesch-Janys, D., Nagel, S., and Waltsgott, H. (1991). Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet 338, 959—64.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Marrapodi, M., and Chiang, J.Y. (2000). Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J Lipid Res 41, 514—20. Marsman, D.S., Cattley, R.C., Conway, J.G., and Popp, J.A. (1988). Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2- pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res 48, 6739— 44.
  • Marsman, D.S., and Popp, J.A. (1994). Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Carcinogenesis 15, 111—7.[Abstract/Free Full Text]
  • Michalik, L., Desvergne, B., Tan, N.S., Basu-Modak, S., Escher, P., Rieusset, J., Peters, J.M., Kaya, G., Gonzalez, F.J., Zakany, J., Metzger, D., Chambon, P., Duboule, D., and Wahli, W. (2001). Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J Cell Biol 154, 799—814.[Abstract/Free Full Text]
  • Michel, C., Roberts, R.A., Desdouets, C., Isaacs, K.R., and Boitier, E. (2005). Characterization of an acute molecular marker of nongenotoxic rodent hepatocarcinogenesis by gene expression profiling in a long term clofibric acid study. Chem Res Toxicol 18, 611—8.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Miller, L.J. and Chacko, R. (2004). The role of cholesterol and statins in Alzheimer's disease. Ann Pharmacother 38, 91—8.[Abstract/Free Full Text]
  • Miller, R.T., Glover, S.E., Stewart, W.S., Corton, J.C., Popp, J.A., and Cattley, R.C. (1996). Effect on the expression of c-met, c-myc and ppar-a in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643. Carcinogenesis 17, 1337—41. Mimura, J., and Fujii-Kuriyama, Y. (2003 ). Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 1619, 263—8.[Medline] [Order article via Infotrieve]
  • Moennikes, O., Loeppen, S., Buchmann, A., Andersson, P., Ittrich, C., Poellinger, L., and Schwarz, M. (2004). A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res 64, 4707—10.[Abstract/Free Full Text]
  • Moggs, J.G. (2005). Molecular responses to xenoestrogens: mechanistic insights from toxicogenomics. Toxicology 213, 177—93.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Moore, J.T., and Kliewer, S.A. (2000). Use of the nuclear receptor PXR to predict drug interactions. Toxicology 153, 1—10.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Moore, J.T., Moore, L.B., Maglich, J.M., and Kliewer, S.A. (2003). Functional and structural comparison of PXR and CAR. Biochim Biophys Acta 1619, 235—8.[Medline] [Order article via Infotrieve]
  • Morgan, K.T., Jayyosi, Z., Hower, M.A., Pino, M.V., Connolly, T.M., Kotlenga, K., Lin, J., Wang, M., Schmidts, H.L., Bonnefoi, M.S., Elston, T.C., and Boorman, G.A. (2005). The hepatic transcriptome as a window on whole-body physiology and pathophysiology. Toxicol Pathol 33, 136—45.[Abstract/Free Full Text]
  • Morimura, K., Cheung, C., Ward, J.M., Reddy, J.K., and Gonzalez, F.J. (2006). Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis. Carcinogenesis 27, 1074—80.[Abstract/Free Full Text]
  • Mukherjee, R., Jow, L., Noonan, D., and McDonnell, D.P. (1994). Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators. J Steroid Biochem Mol Biol 51, 157—66.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Nelson, D.R., Zeldin, D.C., Hoffman, S.M., Maltais, L.J., Wain, H.M., and Nebert, D.W. (2004). Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14, 1—18.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Nikitin, A., Egorov, S., Daraselia, N., and Mazo, I. (2003). Pathway studio—the analysis and navigation of molecular networks. Bioinformatics 19, 2155— 7.[Abstract/Free Full Text]
  • Palmer, C.N., Hsu, M.H., Griffin, K.J., Raucy, J.L., and Johnson, E.F. (1998). Peroxisome proliferator activated receptor-alpha expression in human liver. Mol Pharmacol 53, 14—22.[Abstract/Free Full Text]
  • Parks, D.J., Blanchard, S.G., Bledsoe, R.K., Chandra, G., Consler, T.G., Kliewer, S.A., Stimmel, J.B., Willson, T.M., Zavacki, A.M., Moore, D.D., and Lehmann, J.M. (1999). Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365—8.[Abstract/Free Full Text]
  • Parzefall, W., Berger, W., Kainzbauer, E., Teufelhofer, O., Schulte-Hermann, R., and Thurman, R.G. (2001). Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis 22, 519— 23.
  • Pauli-Magnus, C., Stieger, B., Meier, Y., Kullak-Ublick, G.A., and Meier, P.J. (2005). Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol 43, 342—57.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Peraza, M.A., Burdick, A.D., Marin, H.E., Gonzalez, F.J., and Peters, J.M. (2005). The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci
  • Peters, J.M., Aoyama, T., Cattley, R.C., Nobumitsu, U., Hashimoto, T., and Gonzalez, F.J. (1998). Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis 19, 1989—94.[Abstract/Free Full Text]
  • Peters, J.M., Cattley, R.C., and Gonzalez, F.J. (1997). Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis 18, 2029—33.[Abstract/Free Full Text]
  • Peters, J.M., Lee, S.S., Li, W., Ward, J.M., Gavrilova, O., Everett, C., Reitman, M.L., Hudson, L.D., and Gonzalez, F.J. (2000). Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol Cell Biol 20, 5119—28.[Abstract/Free Full Text]
  • Picard, F., and Auwerx, J. (2002). PPAR(gamma) and glucose homeostasis. Annu Rev Nutr 22, 167—97.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Pirotte, J.H. (1984). Apparent potentiation of hepatotoxicity from small doses of acetaminophen by phenobarbital. Ann Intern Med 101, 403.[ISI][Medline] [Order article via Infotrieve]
  • Platt, D.S. and Cockrill, B.L. (1967). Liver enlargement and hepatoxicity: an investigation into the effects of several agents on rat liver enzyme activities. Biochem Pharmacol 16, 2257—70.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Puga, A., Maier, A., and Medvedovic, M. (2000). The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem Pharmacol 60, 1129— 42.
  • Reddy, J.K., and Krishnakantha, T.P. (1975). Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science 190, 787—9.[Abstract/Free Full Text]
  • Reddy, J.K. and Lalwani, N.D. (1983). Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers in humans. CRC Crit Rev Toxicol 12, 1—58.[Medline] [Order article via Infotrieve]
  • Rendic, S., and Di Carlo, F.J. (1997). Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. g Drug Metab Rev 29, 413—580.[ISI][Medline] [Order article via Infotrieve]
  • Repa, J.J., Liang, G., Ou, J., Bashmakov, Y., Lobaccaro, J.M., Shimomura, I., Shan, B., Brown, M.S., Goldstein, J.L., and Mangelsdorf, D.J. (2000). Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 14, 2819—30.[Abstract/Free Full Text]
  • Riva, M.A., Molteni, R., and Racagni, G. (1998). Differential regulation of FGF-2 and FGFR-1 in rat cortical astrocytes by dexamethasone and isoproterenol. Brain Res Mol Brain Res 57, 38—45.[CrossRef][Medline] [Order article via Infotrieve]
  • Roberts, R.A., James, N.H., Hasmall, S.C., Holden, P.R., Lambe, K., Macdonald, N., West, D., Woodyatt, N.J., and Whitcome, D. (2000). Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha. Toxicol Lett 112—113, 49—57.[CrossRef]
  • Rosenfeld, J.M., Vargas, R., Jr., Xie, W., and Evans, R.M. (2003). Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol Endocrinol 17, 1268—82.[Abstract/Free Full Text]
  • Rusyn, I., Tsukamoto, H., and Thurman, R.G. (1998). WY-14,643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes. Carcinogenesis 19, 1217—22.[Abstract/Free Full Text]
  • Schmidt, A., Endo, N., Rutledge, S.J., Vogel, R., Shinar, D., and Rodan, G.A. (1992). Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 6, 1634—41.[Abstract]
  • Schrenk, D. (1998). Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics. Biochem Pharmacol 55, 1155—62.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Schuetz, E.G., Strom, S., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., Lamba, J., Kim, R.B., Ramachandran, V., Komoroski, B.J., Venkataramanan, R., Cai, H., Sinal, C.J., Gonzalez, F.J., and Schuetz, J.D. (2001). Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 276, 39411—8.[Abstract/Free Full Text]
  • Schuster, D., and Langer, T. (2005). The identification of ligand features essential for PXR activation by pharmacophore modeling. J Chem Inf Model 45, 431—9.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Sheehan, D.J., Hitchcock, C.A., and Sibley, C.M. (1999). Current and emerging azole antifungal agents. Clin Microbiol Rev 12, 40—79.[Abstract/Free Full Text]
  • Shulman, A.I., and Mangelsdorf, D.J. (2005). Retinoid x receptor heterodimers in the metabolic syndrome. N Engl J Med 353, 604—15.[Free Full Text]
  • Sinal, C.J., Yoon, M., and Gonzalez, F.J. (2001). Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids. J Biol Chem 276, 47154—62.[Abstract/Free Full Text]
  • Sinclair, J., Jeffery, E., Wrighton, S., Kostrubsky, V., Szakacs, J., Wood, S., and Sinclair, P. (1998). Alcohol-mediated increases in acetaminophen hepatotoxicity: role of CYP2E and CYP3A. Biochem Pharmacol 55, 1557— 65.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Singaraja, R.R., Bocher, V., James, E.R., Clee, S.M., Zhang, L.H., Leavitt, B.R., Tan, B., Brooks-Wilson, A., Kwok, A., Bissada, N., Yang, Y.Z., Liu, G., Tafuri, S.R., Fievet, C., Wellington, C.L., Staels, B., and Hayden, M.R. (2001). Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem 276, 33969—79.[Abstract/Free Full Text]
  • Snawder, J.E., Roe, A.L., Benson, R.W., and Roberts, D.W. (1994). Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: relation to toxicity. Biochem Biophys Res Commun 203, 532—9.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Song, J., Clagett-Dame, M., Peterson, R.E., Hahn, M.E., Westler, W.M., Sicinski, R.R., and DeLuca, H.F. (2002). A ligandforthe aryl hydrocarbon receptor isolated from lung. Proc Natl Acad Sci USA 99, 14694—9.[Abstract/Free Full Text]
  • Stanley, L.A., Adams, D.J., Lindsay, R., Meehan, R.R., Liao, W., and Wolf, C.R. (1988). Potentiation and suppression of mouse liver cytochrome P-450 isozymes during the acute-phase response induced by bacterial endotoxin. Eur J Biochem 174, 31—6.[ISI][Medline] [Order article via Infotrieve]
  • Steinmetz, A.C., Renaud, J.P., and Moras, D. (2001). Binding of ligands and activation of transcription by nuclear receptors. Annu Rev Biophys Biomol Struct 30, 329—59.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Stulnig, T.M., Steffensen, K.R., Gao, H., Reimers, M., Dahlman-Wright, K., Schuster, G.U., and Gustafsson, J.A. (2002). Novel roles of liver X receptors exposed by gene expression profiling in liver and adipose tissue. Mol Pharmacol 62, 1299—305.[Abstract/Free Full Text]
  • Sucov, H.M., Dyson, E., Gumeringer, C.L., Price, J., Chien, K.R., and Evans, R.M. (1994). RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 8, 1007—18.[Abstract/Free Full Text]
  • Sugatani, J., Kojima, H., Ueda, A., Kakizaki, S., Yoshinari, K., Gong, Q.H., Owens, I.S., Negishi, M., and Sueyoshi, T. (2001). The phenobarbital response enhancer module in the human bilirubin UDPglucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33, 1232—8.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Sun, H., Charles, C.H., Lau, L.F., and Tonks, N.K. (1993). MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487—93.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Synold, T.W., Dussault, I., and Forman, B.M. (2001). The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7, 584—90.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Tachibana, K., Kobayashi, Y., Tanaka, T., Tagami, M., Sugiyama, A., Katayama, T., Ueda, C., Yamasaki, D., Ishimoto, K., Sumitomo, M., Uchiyama, Y., Kohro, T., Sakai, J., Hamakubo, T., Kodama, T., and Doi, T. (2005). Gene expression profiling of potential peroxisome proliferator-activated receptor (PPAR) target genes in human hepatoblastoma cell lines inducibly expressing different PPAR isoforms. Nucl Recept 3, 3.[CrossRef][Medline] [Order article via Infotrieve]
  • Tan, N.S., Michalik, L., Desvergne, B., and Wahli, W. (2003). Peroxisome proliferator-activated receptor (PPAR)-beta as a target for wound healing drugs: what is possible? Am J Clin Dermatol 4, 523—30.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Thummel, K.E., Lee, C.A., Kunze, K.L., Nelson, S.D., and Slattery, J.T. (1993). Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol 45, 1563—9.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Tien, E.S., Gray, J.P., Peters, J.M., and Vanden Heuvel, J.P. (2003). Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes. Cancer Res 63, 5767— 80.[Abstract/Free Full Text]
  • Tijet, N., Boutros, P.C., Moffat, I.D., Okey, A.B., Tuomisto, J., and Pohjanvirta, R. (2006). Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol Pharmacol 69, 140—53.[Abstract/Free Full Text]
  • Tonge, R.P., Kelly, E.J., Bruschi, S.A., Kalhorn, T., Eaton, D.L., Nebert, D.W., and Nelson, S.D. (1998). Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null mice. Toxicol Appl Pharmacol 153, 102—8.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Tugwood, J.D., Issemann, I., Anderson, R.G., Bundell, K.R., McPheat, W.L., and Green, S. (1992). The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene. EMBO J 11, 433—9.[ISI][Medline] [Order article via Infotrieve]
  • Tully, D.B., Bao, W., Goetz, A.K., Blystone, C.R., Ren, H., Schmid, J.E., Strader, L.F., Wood, C.R., Best, D.S., Narotsky, M.G., Wolf, D.C., Rockett, J.C., and Dix, D.J. (2006). Gene expression profiling in liver and testis of rats to characterize the toxicity of triazole fungicides. Toxicol Appl Pharmacol 215, 260—73.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Uchida, D., Kawamata, H., Omotehara, F., Miwa, Y., Hino, S., Begum, N.M., Yoshida, H., and Sato, M. (2000). Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line. Lab Invest 80, 955—63.[ISI][Medline] [Order article via Infotrieve]
  • Ueda, A., Hamadeh, H.K., Webb, H.K., Yamamoto, Y., Sueyoshi, T., Afshari, C.A., Lehmann, J.M., and Negishi, M. (2002). Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol 61, 1—6.[Abstract/Free Full Text]
  • Vairapandi, M., Balliet, A.G., Hoffman, B., and Liebermann, D.A. (2002). GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress. J Cell Physiol 192, 327—38.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Vanden Heuvel, J.P., Kreder, D., Belda, B., Hannon, D.B., Nugent, C.A., Burns, K.A., and Taylor, M.J. (2003). Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY 14,643. Toxicol Appl Pharmacol 188, 185—98.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Vanden Heuvel, J.P., Thompson, J.T., Frame, S.R., and Gillies, P.J. (2006). Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci 92, 476—89.[Abstract/Free Full Text]
  • Vasudevan, A.R., and Balasubramanyam, A. (2004). Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability. Diabetes Technol Ther 6, 850—63.[CrossRef][Medline] [Order article via Infotrieve]
  • Vazquez, J.J., and Marigil, M.A. (1989). Liver-cell adenoma in an epileptic man on barbiturates. Histol Histopathol 4, 301—3.[ISI][Medline] [Order article via Infotrieve]
  • Vezina, C.M., Walker, N.J., and Olson, J.R. (2004). Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expression. Environ Health Perspect 112, 1636—44.[ISI][Medline] [Order article via Infotrieve]
  • Viluksela, M., Stahl, B.U., and Rozman, K.K. (1995). Tissue-specific effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) on the activity of phosphoenolpyruvate carboxykinase (PEPCK) in rats. Toxicol Appl Pharmacol 135, 308—15.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Volz, D.C., Hinton, D.E., Law, J.M., and Kullman, S.W. (2006). Dynamic gene expression changes precede dioxin-induced liver pathogenesis in medaka fish. gToxicol Sci 89, 524—34.[Abstract/Free Full Text]
  • Wan, Y.J., An, D., Cai, Y., Repa, J.J., Hung-Po, C.T., Flores, M., Postic, C., Magnuson, M.A., Chen, J., Chien, K.R., French, S., Mangelsdorf, D.J., and Sucov, H.M. (2000a). Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 20, 4436—44.[Abstract/Free Full Text]
  • Wan, Y.J., Cai, Y., Lungo, W., Fu, P., Locker, J., French, S., and Sucov, H.M. (2000b). Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice. J Biol Chem 275, 28285—90.[Abstract/Free Full Text]
  • Waring, J.F., Gum, R., Morfitt, D., Jolly, R.A., Ciurlionis, R., Heindel, M., Gallenberg, L., Buratto, B., and Ulrich, R.G. (2002). Identifying toxic mechanisms using DNA microarrays: evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor. Toxicology 181—182, 537—50.[CrossRef]
  • Watkins, R.E., Maglich, J.M., Moore, L.B., Wisely, G.B., Noble, S.M., Davis-Searles, P.R., Lambert, M.H., Kliewer, S.A., and Redinbo, M.R. (2003). 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 42, 1430—8.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Watkins, R.E., Wisely, G.B., Moore, L.B., Collins, J.L., Lambert, M.H., Williams, S.P., Willson, T.M., Kliewer, S.A., and Redinbo, M.R. (2001). The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292, 2329—33.[Abstract/Free Full Text]
  • Waxman, D.J. (1999). P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch Biochem Biophys 369, 11—23.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  • Waxman, D.J., and Azaroff, L. (1992). Phenobarbital induction of cytochrome P-450 gene expression. Biochem J 281 ( Pt 3), 577—92.[ISI][Medline] [Order article via Infotrieve]